ada guidelines pregnancy glp-1 receptor agonist discontinue before conception AJOG Expert Review: Glucagon-like peptide-1 use in pregnancy: a review https://ow.ly/PTC950UCtoK Taking GLP-1s during the first
Description
THURSDAY, Dec
Discover how once-monthly maridebart cafraglutide for the treatment of obesity works, its clinical trial evidence, potential eligibility criteria, side effects, and the pathway to NHS access if approved by UK regulators.
Glucagon-like-peptide-1 receptor agonists (GLP-1s) have transformed weight management and treatment of chronic disease
Purpose of Review The development of long-acting incretin receptor agonists represents a significant advance in the fight against the concurrent epidemics of type 2 diabetes mellitus (T2DM) and obesity
GLP-1 medications such as Ozempic may help lower the risk of certain cancers.
